Overview
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2021
Where the money goes
Where each dollar of revenue went, fiscal 2021
- Research and development100¢$38.0M
- Interest0¢$125.0K
- Income tax0¢$56.0K
Out of $20.1M in revenue.2 The company lost money this year.
Financial statements
No quarterly figures reported.
No quarterly figures reported.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|
| Cash | $4.3M4 | $26.1M4 | $11.5M2 | $814.0K2 | $25.5M2 | $32.3M2 |
| Receivables | $8.3M2 | |||||
| Current assets | $43.7M2 | |||||
| Property, plant and equipment | $464.0K2 | |||||
| Intangible assets | $1.9M2 | |||||
| Total assets | $29.7M4 | $21.9M4 | $3.4M6 | $29.8M2 | $47.2M2 | |
| Current liabilities | $10.9M2 | |||||
| Total liabilities | $20.1M4 | $17.7M4 | $15.1M6 | $43.6M2 | $11.9M2 | |
| Retained earnings | -$253.9M2 | |||||
| Shareholders’ equity | $594.6K4 | $9.6M4 | $4.2M6 | -$11.7M2 | -$13.8M2 | $35.3M2 |
| Shares outstanding | 21.7M shares7 | 39.9M shares4 | 83.2M shares6 | 111.2M shares2 |
What it owns
What TITAN MEDICAL INC reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Property and equipment, net | $464.0K2 Dec 31, 2021 | $245.0K2 Dec 31, 2020 | +89.4% |
| Operating-lease assets (leased space) | $1.2M2 Dec 31, 2021 | $867.0K2 Dec 31, 2020 | +35.8% |
Investments
| Item | Latest | A year before | Change |
|---|---|---|---|
| Cash and cash equivalents | $32.3M2 Dec 31, 2021 | $25.5M2 Dec 31, 2020 | +26.8% |
Intangibles and goodwill
Filings
96 filings to the SEC since October 2021: 1 annual reports, 95 other. The latest 20:
- Apr 19, 202315-15D EDGAR
- Apr 10, 2023EFFECT EDGAR
- Apr 10, 2023EFFECT EDGAR
- Apr 5, 2023S-8 POS EDGAR
- Apr 5, 2023S-8 POS EDGAR
- Apr 5, 2023S-8 POS EDGAR
- Apr 5, 2023S-8 POS EDGAR
- Apr 5, 2023AW AMENDMENT WITHDRAWAL EDGAR
- Apr 5, 2023AW AMENDMENT WITHDRAWAL EDGAR
- Apr 5, 2023AW AMENDMENT WITHDRAWAL EDGAR
- Apr 5, 2023AW AMENDMENT WITHDRAWAL EDGAR
- Apr 4, 2023POS AM POST-EFFECTIVE AMENDMENT NO. 1 TO FORM F-3 EDGAR
- Apr 4, 2023POS AM POST-EFFECTIVE AMENDMENT NO. 1 FORM S-8 EDGAR
- Apr 4, 2023POS AM POST-EFFECTIVE AMENDMENT NO. 1 FORM S-8 EDGAR
- Apr 4, 2023POS AM POST-EFFECTIVE AMENDMENT NO. 2 TO FORM F-3 EDGAR
- Apr 4, 2023POS AM POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 EDGAR
- Apr 4, 2023POS AM POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 EDGAR
- Apr 4, 202325 EDGAR
- Apr 4, 20236-K EDGAR
- Apr 3, 20236-K EDGAR
The 96 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
SEC filer profile
How TITAN MEDICAL INC is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARTITAN MEDICAL INC1
- CIK0000840551
- Filer statusNon-accelerated filer<br>emerging growth company1
- Incorporated inOntario, Canada1
- Fiscal year endsDecember 311
- Industry code (SIC)3841 Surgical & Medical Instruments & Apparatus1
- Business address155 University Avenue, Suite 750, Toronto, A6 M5H 3B71
- Phone416-548-7522 X1531
- Shares outstanding111,202,690 as of Dec 31, 20212
- On EDGAR sinceMar 28, 20121
- Filings305 in all: 6-K (217), D (7), POS AM (7), EFFECT (6), SC 13G (6), 424B5 (5), 6-K/A (4), AW (4)1
All 31 form types
CORRESP (4), F-10/A (4), F-X (4), S-8 (4), S-8 POS (4), UPLOAD (4), F-10 (3), SC 13G/A (3), 20-F (2), 40-F (2), 424B3 (2), F-3 (2), 15-15D (1), 20-F/A (1), 25 (1), 40FR12B (1), CERT (1), D/A (1), DRS (1), DRS/A (1), DRSLTR (1), F-1 (1), F-1/A (1)
- Latest filingsAnnual report (20-F) Mar 24, 2022
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7